Investors are demanding a new CEO from outside

Werner Bauman

The Bayer boss will vacate his post by April 2024 at the latest.

(Photo: imago images/sepp spiegl)

Dusseldorf, Frankfurt The entry of several activist investors into Bayer continues to drive the group’s share price up strongly. Since Monday, stocks on the stock exchange have gained a good ten percent after the investments in the company by the hedge funds Inclusive Capital from the USA and Bluebell from London became known.

The timing is no coincidence: The activist funds want to get involved in Bayer’s agenda in a crucial year – which includes the search for a new CEO.

The selection process for the new top management is currently under the direction of Supervisory Board Chairman Norbert Winkeljohann. CEO Werner Baumann will vacate his post as planned by the end of April 2024 at the latest. Research by the Handelsblatt has now shown that not only hedge funds, but also large German shareholders want a successor from outside.

Read on now

Get access to this and every other article in the

Web and in our app free of charge for 4 weeks.

Continue

Read on now

Get access to this and every other article in the

Web and in our app free of charge for 4 weeks.

Continue

source site-13